MD1781G2 - Method of cicatrice formation prophylaxis - Google Patents
Method of cicatrice formation prophylaxis Download PDFInfo
- Publication number
- MD1781G2 MD1781G2 MDA20010078A MD20010078A MD1781G2 MD 1781 G2 MD1781 G2 MD 1781G2 MD A20010078 A MDA20010078 A MD A20010078A MD 20010078 A MD20010078 A MD 20010078A MD 1781 G2 MD1781 G2 MD 1781G2
- Authority
- MD
- Moldova
- Prior art keywords
- cicatrice
- formation
- prophylaxis
- skin
- criotherapy
- Prior art date
Links
- 230000015572 biosynthetic process Effects 0.000 title abstract 2
- 238000000034 method Methods 0.000 title 1
- 238000011321 prophylaxis Methods 0.000 title 1
- 238000011477 surgical intervention Methods 0.000 abstract 2
- 239000013543 active substance Substances 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 abstract 1
- 229960003350 isoniazid Drugs 0.000 abstract 1
- QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Landscapes
- Cosmetics (AREA)
Abstract
The invention relates to the cosmetic dermatology and it is destined for the prevention of cicatrice formation on the skin after criotherapy and after carrying out of surgical interventions.Summary of the invention consists in that on the skin in the place of surgical intervention it is administered during 2…3 hours a remedy containing an effective quantity of isoniazid in the capacity of active agent.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20010078A MD1781G2 (en) | 2001-03-27 | 2001-03-27 | Method of cicatrice formation prophylaxis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20010078A MD1781G2 (en) | 2001-03-27 | 2001-03-27 | Method of cicatrice formation prophylaxis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD1781F1 MD1781F1 (en) | 2001-11-30 |
| MD1781G2 true MD1781G2 (en) | 2002-05-31 |
Family
ID=19739786
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDA20010078A MD1781G2 (en) | 2001-03-27 | 2001-03-27 | Method of cicatrice formation prophylaxis |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD1781G2 (en) |
-
2001
- 2001-03-27 MD MDA20010078A patent/MD1781G2/en not_active IP Right Cessation
Non-Patent Citations (1)
| Title |
|---|
| Lanigon S. W., Robinson T. W. E. Cryotherapy for dermatofibromos. Clin. exp. Dermatol., 1987, v. 12, nr. 2, p. 121-123 * |
Also Published As
| Publication number | Publication date |
|---|---|
| MD1781F1 (en) | 2001-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| YU66600A (en) | Pharmaceutical compositions capable of being gelled | |
| AU3079799A (en) | Protease inhibitors in absorbent articles | |
| FR2728793B1 (en) | ||
| ATE293434T1 (en) | PHARMACEUTICAL COMPOSITIONS WHICH CONTAIN KUKUI NUT OIL | |
| PL309604A1 (en) | Pharmaceutical composition for treating nicotin dependence | |
| EP0834320A4 (en) | Drug composition comprising albumin as active ingredient | |
| EP1050300B1 (en) | Selective antibacterial composition | |
| IL131811A0 (en) | Antitussive compositions | |
| DK0759740T3 (en) | Use of laminarine and oligosaccharides derived from laminarine in cosmetology and in the manufacture of a medicament intended for the treatment of the skin | |
| JP2004508317A5 (en) | ||
| CZ20011550A3 (en) | Optically active derivative of pyridyl-4H-1,2,4-oxadiazine, use thereof when treating vascular diseases and pharmaceutical compositions in which it is comprised | |
| EP0744176A3 (en) | Methods for inhibiting bone loss | |
| GB2331301A (en) | Galanin | |
| WO2001068076A3 (en) | D-enantiomer of dfmo and methods of use thereof for treating cancer | |
| MD1781F1 (en) | Method of cicatrice formation prophylaxis | |
| ATE168004T1 (en) | ITCH RELIEF | |
| LT96094A (en) | The active ingredient of pharmaceutical composition for treating constipation | |
| AU7941294A (en) | Composition for the treatment or prevention of herpes | |
| EP0653936A1 (en) | Use of 2-(4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone for the treatment of cancer. | |
| AU4519289A (en) | Medicament for the treatment of cryptosporidiosis | |
| JP2826141B2 (en) | Dandruff inhibitor composition | |
| RU2190388C1 (en) | Preparation on base of tea tree oil (versions) | |
| GB2246954A (en) | Pharmaceutical anti-infective composition containing metronidazole | |
| JP2006335761A (en) | Sustained release deodorizing composition | |
| DE69428276D1 (en) | INSULIN-LIKE GROWTH FACTOR II AS AN ANTITUARY AGENT |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
| MM4A | Patent for invention definitely lapsed due to non-payment of fees |